Charles River Laboratories International Aktie
WKN: 939391 / ISIN: US1598641074
|
05.11.2025 14:23:22
|
Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates
(RTTNews) - Charles River Laboratories International Inc. (CRL) reported a profit for third quarter that Decreased from last year but beat the Street estimates.
The company's bottom line came in at $54.4 million, or $1.10 per share. This compares with $69.6 million, or $1.33 per share, last year.
Excluding items, Charles River Laboratories International Inc. reported adjusted earnings of $2.43 per share for the period.
Analysts on average had expected the company to earn $2.34 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 0.5% to $1.004 billion from $1.009 billion last year.
Charles River Laboratories International Inc. earnings at a glance (GAAP) :
-Earnings: $54.4 Mln. vs. $69.6 Mln. last year. -EPS: $1.10 vs. $1.33 last year. -Revenue: $1.004 Bln vs. $1.009 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
| Charles River Laboratories International Inc. | 147,35 | -4,32% |
|